Mattias Magnusson Selected Research

methylated bovine serum albumin (MBSA)

8/2020	Local administration of 4-Thiouridine, a novel molecule with potent anti-inflammatory properties, protects against experimental colitis and arthritis.
1/2018	Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.
10/2016	IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.
1/2015	Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis.
10/2013	Interferon alpha inhibits antigen-specific production of proinflammatory cytokines and enhances antigen-specific transforming growth factor beta production in antigen-induced arthritis.
2/2011	Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattias Magnusson Research Topics

Disease

16	Arthritis (Polyarthritis) 01/2021 - 01/2006
9	Inflammation (Inflammations) 08/2020 - 01/2006
6	Rheumatoid Arthritis 01/2021 - 01/2009
3	Lung Diseases (Lung Disease) 01/2022 - 10/2020
3	Leukemia 12/2017 - 05/2007
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 10/2020
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2006
2	Edema (Dropsy) 08/2020 - 03/2006
2	Pneumonia (Pneumonitis) 08/2020 - 01/2015
2	Colitis 08/2020 - 01/2017
2	Staphylococcal Infections 08/2011 - 01/2005
2	Infections 10/2010 - 06/2007
1	Idiopathic Pulmonary Fibrosis 01/2022
1	COVID-19 01/2022
1	Acute Promyelocytic Leukemia 10/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021
1	Hypoxia (Hypoxemia) 03/2021
1	Pre-Eclampsia (Preeclampsia) 03/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Infectious Arthritis (Septic Arthritis) 08/2011
1	Shock 08/2011
1	Sepsis (Septicemia) 08/2011
1	Autoimmune Diseases (Autoimmune Disease) 06/2011
1	Osteoarthritis 11/2008
1	Multiple Sclerosis 06/2008
1	Gastroesophageal Reflux (GERD) 06/2008
1	Hypersensitivity (Allergy) 03/2006
1	Gout 03/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2004

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 08/2020 - 09/2003
6	methylated bovine serum albumin (MBSA)IBA 08/2020 - 02/2011
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 06/2008
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2006
5	CytokinesIBA 08/2020 - 11/2008
3	Interferon-alpha (Interferon Alfa)IBA 10/2013 - 09/2003
2	Messenger RNA (mRNA)IBA 03/2021 - 08/2020
2	KynurenineIBA 01/2018 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 11/2017
2	UridineIBA 01/2017 - 01/2015
2	Nucleic AcidsIBA 04/2014 - 03/2006
2	Double-Stranded RNA (RNA, Double Stranded)IBA 04/2014 - 01/2006
1	ApoferritinsIBA 01/2022
1	DiterpenesIBA 10/2021
1	alpha-GlobinsIBA 03/2021
1	Fetal Hemoglobin (Hemoglobin F)IBA 03/2021
1	GlobinsIBA 03/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	ThiouridineIBA 08/2020
1	sephadexIBA 08/2020
1	Peroxidase (Myeloperoxidase)IBA 08/2020
1	NucleosidesIBA 08/2020
1	Phosphotransferases (Kinase)IBA 08/2020
1	Drinking WaterIBA 08/2020
1	Dextrans (Dextran)FDA Link 08/2020
1	SodiumIBA 08/2020
1	Sulfhydryl Compounds (Thiols)IBA 08/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	Diphtheria ToxinIBA 01/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018
1	Dextran SulfateIBA 01/2017
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2013
1	Freund's AdjuvantIBA 10/2013
1	Enterotoxins (Enterotoxin)IBA 08/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011
1	Tumor Necrosis Factor InhibitorsIBA 08/2011
1	Hemostatics (Antihemorrhagics)IBA 08/2011
1	Immunoglobulin G (IgG)IBA 02/2011
1	Galectins (Galectin)IBA 02/2011
1	Galectin 3 (LGALS3)IBA 02/2011
1	Rituximab (Mabthera)FDA Link 10/2010
1	Staphylococcus aureus auR protein (staphylokinase)IBA 10/2010
1	PlasminogenIBA 10/2010
1	Estrogens (Estrogen)FDA Link 01/2009
1	MineralsIBA 01/2009
1	Collagen Type II (Type II Collagen)IBA 01/2009
1	CollagenIBA 01/2009
1	salicylhydroxamic acid (SHAM)IBA 01/2009
1	flt3 ligand protein (flt3 ligand)IBA 01/2008
1	Peptidoglycan (Murein)IBA 01/2008
1	SurvivinIBA 01/2008
1	VaccinesIBA 06/2007
1	LigandsIBA 06/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2007
1	SuspensionsIBA 03/2006
1	Uric Acid (Urate)IBA 03/2006
1	Biological ProductsIBA 03/2006
1	Toll-Like Receptor 3IBA 01/2006
1	Interferon Type IIBA 01/2006
1	CarbohydratesIBA 01/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 08/2011
5	Intra-Articular Injections 08/2020 - 10/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020
1	Immunomodulation 10/2020
1	Subcutaneous Injections 10/2013
1	Immunotherapy 06/2007